Immunological treatment for multiple sclerosis.
D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007372:Interferons / Q000009:adverse effects; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*
D007166:Immunosuppressive Agents; D007372:Interferons